Health and Healthcare

Gilead Sciences : GILD

All Gilead Sciences Articles

730 Articles

Chris Lange | Aug 26, 2015 at 8:55 AM EDT

Short Sellers Become More Focused in Major Biotechs

The short interest data are out for the August 14 settlement date. Biotech companies are considered a riskier group of…

Jon C. Ogg | Aug 24, 2015 at 11:35 AM EDT

Projected Prices Where Investors Are Interested: Apple, JPMorgan, Ford, GE, Gilead

24/7 Wall St. has wanted to check on the major stocks in the market with an eagle-eye view of where…

Chris Lange | Aug 12, 2015 at 8:55 AM EDT

Short Sellers Run for Cover From Major Biotechs

The short interest data are out for the July 31 settlement date, and overall, short interest in the selected biotech…

Chris Lange | Jul 29, 2015 at 1:27 PM EDT

Should Gilead Really Be Rated Underperform?

ThinkstockMost analysts seem to be behind the growth that Gilead Sciences Inc. (NASDAQ: GILD) has seen, namely in its Hepatitis…

Jon C. Ogg | Jul 29, 2015 at 8:54 AM EDT

Top Analyst Upgrades and Downgrades: Amazon, Citrix, Gilead, Sirius XM, 3D Systems, Twitter, Yelp and Many More

Jon OggStocks were indicated higher on Wednesday ahead of the pending FOMC decision on interest rates. Tuesday’s rally was yet…

Chris Lange | Jul 28, 2015 at 4:54 PM EDT

Gilead Tops Estimates in 2Q

courtesy of Gilead SciencesGilead Sciences Inc. (NASDAQ: GILD) reported second-quarter financial results Tuesday after the markets closed. The biotech giant…

Chris Lange | Jul 27, 2015 at 7:57 AM EDT

Short Sellers Back Off Major Biotechs

ThinkstockThe short interest data are out for the July 15 settlement date. Biotech companies are considered a riskier group of…

Jon C. Ogg | Jul 26, 2015 at 10:21 AM EDT

BioPharma Earnings Bracing for Merck, Pfizer, Amgen, Gilead

ThinkstockPharmaceutical and Biotech investors are about to get a real show for earnings this week. Big Pharma will bring earnings…

Jon C. Ogg | Jul 21, 2015 at 8:45 AM EDT

Top Analyst Upgrades and Downgrades: Alarm.com, Pandora, PayPal, SanDisk, SunEdison, Tesla, AMD and More

Tuesday's top analyst upgrades, downgrades and initiations include Alarm.com, Pandora Media, PayPal, SanDisk, SunEdison, Tesla Motors and Advanced Micro Devices.

Chris Lange | Jul 13, 2015 at 7:55 AM EDT

Short Sellers Back Off Big Biotech

24/7 Wall St. has reviewed the short interest in top biotech companies, without focusing on speculative companies.

Chris Lange | Jul 6, 2015 at 1:45 PM EDT

Is Gilead Headed Lower From Here?

Merrill Lynch recently updated its view on Gilead Sciences, maintaining its Underperform rating for the stock but raising its price…

Chris Lange | Jun 25, 2015 at 7:50 AM EDT

Short Sellers Get More Selective on Big Biotech

The short interest data are out for the June 15 settlement date, and overall, short interest in the selected biotech…

Chris Lange | Jun 10, 2015 at 7:55 AM EDT

Short Sellers Lose Some Conviction Against Big Biotech

The May 29 short interest data have been compared with the previous figures, and for most of the selected biotech…

Chris Lange | May 28, 2015 at 8:25 AM EDT

Short Sellers Get Even More Ambitious Against Biotech Leaders

The short interest data are out for the May 15 settlement date. Biotech companies are considered a riskier group of…

Chris Lange | May 24, 2015 at 9:15 AM EDT

Large Companies With Fastest Revenue and Earnings Growth in 2015

S&P Capital IQ released a report regarding the performance of companies in terms of earnings and revenue.

1 … 30 31 32 33 34 … 49

Gilead Sciences : GILD

All Gilead Sciences Articles

Short Sellers Become More Focused in Major Biotechs

Projected Prices Where Investors Are Interested: Apple, JPMorgan, Ford, GE, Gilead

Short Sellers Run for Cover From Major Biotechs

Should Gilead Really Be Rated Underperform?

Top Analyst Upgrades and Downgrades: Amazon, Citrix, Gilead, Sirius XM, 3D Systems, Twitter, Yelp and Many More

Gilead Tops Estimates in 2Q

Short Sellers Back Off Major Biotechs

BioPharma Earnings Bracing for Merck, Pfizer, Amgen, Gilead

Top Analyst Upgrades and Downgrades: Alarm.com, Pandora, PayPal, SanDisk, SunEdison, Tesla, AMD and More

Short Sellers Back Off Big Biotech

Is Gilead Headed Lower From Here?

Short Sellers Get More Selective on Big Biotech

Short Sellers Lose Some Conviction Against Big Biotech

Short Sellers Get Even More Ambitious Against Biotech Leaders

Large Companies With Fastest Revenue and Earnings Growth in 2015

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Gilead Sciences : GILD

All Gilead Sciences Articles

Short Sellers Become More Focused in Major Biotechs

Projected Prices Where Investors Are Interested: Apple, JPMorgan, Ford, GE, Gilead

Short Sellers Run for Cover From Major Biotechs

Should Gilead Really Be Rated Underperform?

Top Analyst Upgrades and Downgrades: Amazon, Citrix, Gilead, Sirius XM, 3D Systems, Twitter, Yelp and Many More

Gilead Tops Estimates in 2Q

Short Sellers Back Off Major Biotechs

BioPharma Earnings Bracing for Merck, Pfizer, Amgen, Gilead

Top Analyst Upgrades and Downgrades: Alarm.com, Pandora, PayPal, SanDisk, SunEdison, Tesla, AMD and More

Short Sellers Back Off Big Biotech

Is Gilead Headed Lower From Here?

Short Sellers Get More Selective on Big Biotech

Short Sellers Lose Some Conviction Against Big Biotech

Short Sellers Get Even More Ambitious Against Biotech Leaders

Large Companies With Fastest Revenue and Earnings Growth in 2015

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

Featured Reads

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%